Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).
Clinical trial NCT05495503 · COMPLETED
Trial details
- NCT number
- NCT05495503
- Sponsor
- Cryonove Pharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2022-12-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.